title: Correction of severe heparin-associated thrombocytopenia with intravenous immunoglobulin.
authors.affiliation: National Naval Medical Center, Bethesda, Maryland.
authors.forename: J N
authors.initials: JN
authors.lastname: Frame
authors.forename: K P
authors.initials: KP
authors.lastname: Mulvey
authors.forename: J C
authors.initials: JC
authors.lastname: Phares
authors.forename: M J
authors.initials: MJ
authors.lastname: Anderson
mesh_terms: D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced / Q000628:therapy; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous; D008875:Middle Aged; D017713:Platelet Transfusion; D011655:Pulmonary Embolism / Q000188:drug therapy; D012008:Recurrence; D013921:Thrombocytopenia / Q000139:chemically induced / Q000628:therapy*; D013924:Thrombophlebitis / Q000188:drug therapy
chemical_list: D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D006493:Heparin